Navigation Links
PharmAthene Reports Third Quarter 2013 Financial And Operational Results
Date:11/7/2013

, in May 2013, the Delaware Supreme Court issued its ruling on the appeal in our litigation with SIGA Technologies, affirming the Court of Chancery's finding that SIGA was liable for breach of contract, reversing its finding of promissory estoppel, and remanding the case back to the Court of Chancery to reconsider the appropriate remedy and award of attorney's fees and expert witness costs in light of the Supreme Court's opinion. For more information about PharmAthene, please visit www.PharmAthene.com.

About TheracloneTheraclone is a biopharmaceutical company focused on the discovery and development of novel, monoclonal antibody therapeutics for diseases that are devastating for patients and their families and which are a significant threat to human health. Theraclone leverages its proprietary antibody discovery technology, I-STAR™ (In-Situ Therapeutic Antibody Rescue), to identify rare human antibodies that may be developed into antibody product candidates that are potentially safer and more effective than current therapies. Theraclone has a portfolio of innovative antibodies in clinical and preclinical development targeting serious medical conditions with a significant unmet medical need and a primary focus on infectious disease and cancer, which include:

  • TCN-032 - a recombinant fully human monoclonal antibody for the treatment of patients hospitalized with serious influenza
  • TCN-202 - a recombinant fully human monoclonal antibody for the treatment and prevention of cytomegalovirus, or CMV infections
  • For more information about Theraclone, please visit www.theraclone-sciences.com. On August 1, 2013, Theraclone and PharmAthene (NYSE MKT: PIP) announced a definitive merger agreement.

    Important Additional Information about the Proposed MergerThis communication is being made in connection with the proposed merger involving PharmAthene
    '/>"/>

    SOURCE PharmAthene, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. PharmAthene to Present at Rodman & Renshaw Annual Global Investment Conference
    2. PharmAthene and Theraclone Sciences Announce Merger Agreement to Create Diversified Biologics Company Targeting Government and Commercial Markets
    3. PharmAthene Reports First Quarter 2013 Financial And Operational Results
    4. New Data Show PharmAthenes Recombinant Bioscavenger Binds To A Broad Spectrum Of Chemical Nerve Agents
    5. SIGA Technologies Files Notice of Appeal in PharmAthene Litigation
    6. Pharmacyclics Reports Third Quarter 2013 Results
    7. CareFusion Reports First Quarter Fiscal 2014 Results
    8. Sequenom, Inc. Reports Financial Results For The Third Quarter Of 2013
    9. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results
    10. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
    11. ANI Pharmaceuticals Reports Net Revenues of $7.8 million, adjusted Non-GAAP EBITDA of $1.7 Million, and EPS of $0.13 for the Third Quarter Ended September 30, 2013
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/7/2015)... SEOUL, South Korea and FREMONT, Calif. ... (NCC) of South Korea and Velos, ... the use of Velos eResearch for cancer research nationally throughout ... with other research partners. The recent agreement signing was accompanied ... in Seoul , South Korea.  ...
    (Date:7/7/2015)... 30, 2015 ... the addition of the "Biomedical Photoacoustic ... offering. This patent landscape focuses ... is a safe, non-invasive, non-ionizing imaging technique. ... a great alternative to traditional medical imaging ...
    (Date:7/7/2015)... , 7 de julio de 2015 /PRNewswire/ ... de propiedad privada centrada en el desarrollo de ... neurovascular, ha anunciado hoy que R. Michael ... directiva. Kleine cuenta con más ... de los dispositivos médicos y la sanidad. Ha ...
    Breaking Medicine Technology:National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 3Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 3Sequent Medical nombra a Mike Kleine a su junta directiva 2Sequent Medical nombra a Mike Kleine a su junta directiva 3
    ... March 11, 2011, the United States District Court for ... a portion of the patent litigation brought by Cephalon ... wholly-owned subsidiary CIMA Labs, Inc., ("CIMA") against Watson Pharmaceuticals, ... "Watson") pertaining to Cephalon,s FENTORA® fentanyl buccal tablet product. ...
    ... (Nasdaq: ONXX ) today announced that it will ... Thursday, March 17, 2011 at 10:15 a.m. Eastern Time (7:15 ... a live webcast of the presentation on our website at: ... recommended that listeners log on 15 minutes early in order ...
    Cached Medicine Technology:Court Rules on First Set of Patents in FENTORA Litigation 2Onyx Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference 2
    (Date:7/7/2015)... ... July 08, 2015 , ... The OR Business Management Conference ... business managers increase efficiency, reduce supply chain costs, optimize throughput, and improve patient ... Phoenix Glendale, February 21-24, 2016. The agenda has been announced and includes four ...
    (Date:7/7/2015)... ... 07, 2015 , ... World Patent Marketing, a vertically integrated ... merges kid's clothing and footwear for maximum comfort and benefit. , “The Children’s ... one of the most lucrative segments in the global apparel industry,” says Scott ...
    (Date:7/7/2015)... , ... July 07, 2015 , ... ... pediatric obesity to better understand what worked (or didn’t) and how similar programs ... in the Healthy Eating Active Living TeleHealth Community of Practice (HEALTH COP) program, ...
    (Date:7/7/2015)... ... July 07, 2015 , ... ... everyday items, recently launched their first line of luxury smart jewelry called the ... is expected to ship this fall. , “The Socialite collection was crafted ...
    (Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... cancer screenings at the Aspen Ideas Festival (AIF), identifying 18 possible melanomas and ... diagnoses must be confirmed with additional testing. , The Aspen Ideas Festival, which ...
    Breaking Medicine News(10 mins):Health News:Agenda, Pre-Conference Workshop, and More Announced for OR Business Management Conference 2Health News:Agenda, Pre-Conference Workshop, and More Announced for OR Business Management Conference 3Health News:Mom Creates Clothing Line and Footwear Product In One For World Patent Marketing's Trendy Selection Of New Apparel Inventions 2Health News:Mom Creates Clothing Line and Footwear Product In One For World Patent Marketing's Trendy Selection Of New Apparel Inventions 3Health News:Mom Creates Clothing Line and Footwear Product In One For World Patent Marketing's Trendy Selection Of New Apparel Inventions 4Health News:Mom Creates Clothing Line and Footwear Product In One For World Patent Marketing's Trendy Selection Of New Apparel Inventions 5Health News:UC Davis Study Identifies Tools, Strategies for Enhancing Obesity Prevention in Rural Communities 2Health News:UC Davis Study Identifies Tools, Strategies for Enhancing Obesity Prevention in Rural Communities 3Health News:WiseWear Unveils Luxury Smart Jewelry Line 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4
    ... Massachusetts Mutual Life,Insurance Company (MassMutual) announced that it ... and Environmental Design for Existing Buildings,(LEED-EB) certification for ... year-long process that includes replacing more than 500,plumbing ... the 1.4,million square foot headquarters truly green. , ...
    ... Foundation,will be presenting its annual Research Overview by the ... (CFC) research consortium,that opens GRF,s 31st Anniversary Benefit and ... Francisco,s legendary Palace Hotel. , ... from being,described as an eye disease to a neurodegenerative ...
    ... Quantros, a leading provider of,safety, quality, and ... for Safe Medication Practices (ISMP), today announced a ... prevention. ISMP will,work with Quantros to provide ... intervention and best practices. Under this,agreement, Quantros ...
    ... Patients should recognise they have to take responsibility for their ... a leading academic. , Durham University,s Martyn Evans ... of Healthcare, annual report (10 December). , Professor Evans argues ... them to look after themselves and others around them, and ...
    ... has expressed concerns that patients with advanced kidney cancer ... treatments because the National Institute for Health and Clinical ... four of the new treatments it has assessed. , ... , Professor Eisen, from the University of Cambridge, points ...
    ... Parents of children with an,autism-spectrum diagnosis have a new ... couldn,t have come at a better time, says Talk About,Curing ... with autism. The rate of autism diagnoses is continuing to ... affected with this,disorder." , ...
    Cached Medicine News:Health News:MassMutual Announces LEED-EB Certification Initiative 2Health News:MassMutual Announces LEED-EB Certification Initiative 3Health News:GRF to Present Groundbreaking Research for Glaucoma at January 28 Gala 2Health News:Quantros and ISMP Announce Collaboration Agreement to Further Medication Safety 2Health News:Quantros and ISMP Announce Collaboration Agreement to Further Medication Safety 3Health News:People who want access to the NHS should behave more responsibly, says expert 2Health News:UK kidney cancer patients face toxic, out-dated treatments with little hope of change 2Health News:UK kidney cancer patients face toxic, out-dated treatments with little hope of change 3Health News:AutismActionPlan.org Launches Doctor-Driven Biomedical Autism Treatment Website 2
    ... The Cool-Tech™/O.R. apron ... patented mesh-back design as ... but comes equipped with ... shoulders as well as ...
    Apron,special Proceddure...
    Protect your thyroid with a personal Thyroid Shield. While other shields have a rough, abrasive bias binding edging the neck, these have a softer, smoother turned seam that helps protect your neck fr...
    Freedom of movement - plus full circle, maximum radiation protection. No other full circle radiation protection design approaches the level of comfort of the VestSkirt, which divides weight between t...
    Medicine Products: